Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Blanquart

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Current Oncology (Toronto, Ont.)|May 27, 2022
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of LiteratureLaurent Mathiot, Guillaume Herbreteau, Siméon Robin, et al.
Chembiochem : a European Journal of Chemical Biology|October 28, 2020
Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell ExtractsJessica Soamalala, Sebastien Diot, Morgan Pellerano, et al.
EMBO Reports|April 4, 2006
Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptorSébastien Nouaille, Christophe Blanquart, Vladimir Zilberfarb, et al.
Molecular Medicine Reports|April 8, 2011
Insulin receptor substrates-5 and -6 are poor substrates for the insulin receptorSoetkin Versteyhe, Christophe Blanquart, Cornelia Hampe, et al.
Biomacromolecules|June 5, 2013
Nanoparticles produced by ring-opening metathesis polymerization using norbornenyl-poly(ethylene oxide) as a ligand-free generic platform for highly selective in vivo tumor targetingFabien Gueugnon, Iza Denis, Daniel Pouliquen, et al.
Molecular Oncology|September 2, 2022
IL-7 is expressed in malignant mesothelioma and has a prognostic valueHoa-Le Mai, Sophie Deshayes, Thi-Van-Ha Nguyen, et al.
The American Journal of Pathology|March 2, 2011
Identification of novel markers for the diagnosis of malignant pleural mesotheliomaFabien Gueugnon, Sabrina Leclercq, Christophe Blanquart, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and ModelingSamuel Bouchet, Camille Linot, Dusan Ruzic, et al.
ACS Applied Materials & Interfaces|August 20, 2019
Hybrid Azo-fluorophore Organic Nanoparticles as Emissive Turn-on Probes for Cellular EndocytosisJoanna Boucard, Tina Briolay, Thibaut Blondy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2012
CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusionsChristophe Blanquart, Fabien Gueugnon, Jean-Michel Nguyen, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Current Oncology (Toronto, Ont.)|May 27, 2022
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of LiteratureLaurent Mathiot, Guillaume Herbreteau, Siméon Robin, et al.
Chembiochem : a European Journal of Chemical Biology|October 28, 2020
Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell ExtractsJessica Soamalala, Sebastien Diot, Morgan Pellerano, et al.
EMBO Reports|April 4, 2006
Interaction with Grb14 results in site-specific regulation of tyrosine phosphorylation of the insulin receptorSébastien Nouaille, Christophe Blanquart, Vladimir Zilberfarb, et al.
Molecular Medicine Reports|April 8, 2011
Insulin receptor substrates-5 and -6 are poor substrates for the insulin receptorSoetkin Versteyhe, Christophe Blanquart, Cornelia Hampe, et al.
Biomacromolecules|June 5, 2013
Nanoparticles produced by ring-opening metathesis polymerization using norbornenyl-poly(ethylene oxide) as a ligand-free generic platform for highly selective in vivo tumor targetingFabien Gueugnon, Iza Denis, Daniel Pouliquen, et al.
Molecular Oncology|September 2, 2022
IL-7 is expressed in malignant mesothelioma and has a prognostic valueHoa-Le Mai, Sophie Deshayes, Thi-Van-Ha Nguyen, et al.
The American Journal of Pathology|March 2, 2011
Identification of novel markers for the diagnosis of malignant pleural mesotheliomaFabien Gueugnon, Sabrina Leclercq, Christophe Blanquart, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and ModelingSamuel Bouchet, Camille Linot, Dusan Ruzic, et al.
ACS Applied Materials & Interfaces|August 20, 2019
Hybrid Azo-fluorophore Organic Nanoparticles as Emissive Turn-on Probes for Cellular EndocytosisJoanna Boucard, Tina Briolay, Thibaut Blondy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2012
CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusionsChristophe Blanquart, Fabien Gueugnon, Jean-Michel Nguyen, et al.
Pageof 8